Approximately one in three Canadians will develop shingles in their lifetime, 1 with increased age and certain chronic conditions linked to a higher risk of shingles 2 , 3 MISSISSAUGA, ON, July 24, ...

Could a drug intended to prevent painful rashes also protect our brains as we get older? The signs are promising – but not conclusive. Yet that’s enough to be driving a boom in shingles jabs ...

Vaccination against herpes zoster (shingles) was tied to significantly less dementia risk, data from Canada's network of primary care records showed. Being eligible for a free live-attenuated zoster ...

Dear Dr. Roach: I recently read this morning that the shingles vaccine, Shingrix, "may have a protective effect against dementia." It goes on to say the studies that have been conducted so far are ...

A large-scale study of 1.5 million Medicare beneficiaries found that the two-dose Shingrix shingles vaccine is linked to a 33% lower risk of dementia in adults over age 65. The recombinant zoster ...

With Shingrix, GSK targets a painful, often underestimated disease that hits adults in midlife and beyond. What the recombinant shingles vaccine promises, where it convinces in the data, and what ...

DEAR DR. ROACH: I recently read this morning that the shingles vaccine, Shingrix, “may have a protective effect against dementia.” It goes on to say the studies that have been conducted so far are ...

Share on Pinterest Shingrix, the current vaccine against shingles, is linked to a lower burden of cardiovascular problems. FG Trade Latin/ Getty Images In 2017, the Food and Drug Administration (FDA) ...

Share on Pinterest Recent research shows that the shingles vaccine may help reduce the risk of cardiovascular disease. A boy and the sea · E+/Getty A recent study found that the recombinant shingles ...

MISSISSAUGA, ON, July 24, 2026 /CNW/ -- GSK Canada today announced the approval of Shingrix (GSK's Recombinant Zoster Vaccine or RZV) in a prefilled syringe. This new presentation removes the need to ...